Merck Serono to Expand Research and Development Presence in ChinaChina's Research and Development Organization Will Become the Fourth Key R&D Hub for Merck Serono Worldwide Nutrition Security for Children in BangladeshA Leaders Roundtable, 24 November 2009, Radisson Water Garden Hotel, Dhaka Bangladesh Vitol and Harvest Energy Announce Improved Terms for Crude Oil Supply and Refined Product Offtake AgreementGENEVA - - This Release was Issued on the Vitol Website on the 14th October 2009. Vitol Refining S.A (”Vitol”) and Harvest Energy Trust (”Harvest”) are pleased to announce that Harvest’s North Atlantic Refining Limited subsidiary (”NARL”) has renewed and extended its existing crude oil supply and refined product offtake agreement (”SOA”) with Vitol. New Genius Inside Project and Portfolio Management Solutions Provide Detailed Control, Strategic Vision Over Complex ProjectsNEW YORK, LINDAU, Germany, MONTREAL, and GENEVA - - Upgraded versions of Genius Project For Web and Domino give users complete visibility and control over projects, from calculating market share to monitoring time spent on one task Pakistani Christians Speak Out at the United NationsGENEVA - Last week the Human Rights Council of the United Nations meeting finished with several new decisions taking place regarding problems in Palestine and Sudan. But a new and urgent issue of Christians in Pakistan was highlighted to the International Community by an International Think Tank, the “International Club for Peace Research”. Quantum Cryptography Network Up and Running for 12,000 HoursGENEVA - The SwissQuantum testbed network was set up in Geneva by the University Of Geneva, the University of Applied Sciences of Western Switzerland and the company id Quantique in order to demonstrate long-term operation of quantum cryptography technology in a meshed network setting. Contrary to quantum networks previously deployed, it is used to carry real traffic and is independently tested. WISeKey and Partners Like Datang Telecom Propose Accelerating Global Deployment of Next Generation SIM Cards as First Line of Defense Against CybercrimeGENEVA, Switzerland - - Indication: Picture can be Downloaded Free of Charge Under: www.presseportal.ch/de/pm/100006027/?langid=2 Vitol, Inc. Enters into Agreement to Purchase the General Partner of SemGroup Energy Partners, L.P.GENEVA - Vitol Inc., part of the Vitol Group of companies (”Vitol”), today entered into an agreement with Manchester Securities Corp., an affiliate of Elliott Management Corporation, to purchase a 100% interest in SemGroup Energy Partners G.P., L.L.C., the general partner of SemGroup Energy Partners, L.P. (”SGLP”) and 12.6 million subordinated units in SGLP. Financial terms of the transaction were not disclosed and consummation of the purchase is subject to customary conditions and approvals. At ITU Telecom World 2009, WISeKey Launches Security Service to Help Companies and Governments Protect Their Customers From Identity Theft and Mobile TransactionsGENEVA - - Indication: Picture of the USB stick ekey+ can be downloaded free of charge under: www.presseportal.ch/de/pm/100006027/?langid=2 Merck Serono Named as a Top Employer by Science MagazineGENEVA - - Merck Serono, the Division for Innovative Biotech and Pharmaceutical Medicines of Merck KGaA, Ranked No. 6 Among 575 Biotech and Pharma Employers Uzbekistan and Europe: Opportunities and Prospects for Expansion of Economic PartnershipGENEVA - - International Round Table The potential for deeper economic ties between Uzbekistan and Europe were discussed at an international round table in Geneva, at the Palais des Nations, last Thursday October 1, 2009. Merck Serono Submits Application for Cladribine Tablets as a Potential Oral Short-Course Multiple Sclerosis Therapy in the United StatesGENEVA - Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the submission of a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for Cladribine Tablets, Merck Serono’s proprietary investigational oral formulation of cladribine, as a therapy for reducing relapses in people with relapsing forms of multiple sclerosis (MS). Cladribine Tablets has the potential to be the first orally administered disease-modifying therapy available for people living with relapsing MS, as all disease-modifying therapies currently approved for the treatment of MS are parenteral therapies. Vitol Upstream Ghana Limited Assigns Interest in Two Ghana Licences to EniGENEVA - Eni announced yesterday that it has entered Ghana through the acquisition of majority stakes in the Offshore Cape Three Points (OCTP) and Offshore Cape Three Points South (OCTPS) exploration licences. Cotecna Thailand Laboratory Certified by GAFTA for Grain and Feeding Stuffs AnalysisGENEVA, Switzerland - Cotecna Inspection (Thailand) Co. Ltd, Bangkok, is now accredited by GAFTA (Grain and Feed Trade Association) to issue analysis certificates for grain and feeding stuffs at loading and discharging ports. Merck Serono Growth Hormone Injection Device easypod(R) Approved in JapanGENEVA - Merck Serono, a division of Merck KGaA Darmstadt, Germany, today announced that the Japanese health authorities, the Pharmaceutical and Medical Devices Agency (PMDA), have granted a marketing authorization for easypod(R) in Japan. Easypod(R) was developed for exclusive use with cartridges of Saizen(R) (somatropin), Merck Serono’s human recombinant growth hormone for the treatment of growth hormone deficiency. /C O R R E C T I O N — Merck Serono S A/GENEVA - In the news release, “Merck Serono Growth Hormone Injection Device easypod(R) Approved in Japan” issued on 16 Sep 2009 07:00 GMT, by Merck Serono S A SWX:SEO over PR Newswire, we are advised by a representative of the company that the last sentence of the fourth paragraph has been changed from “In Japan, easypod(R) will be launched in September 2009″ to “In Japan, easypod(R) will be launched in the course of 2009″ as originally issued inadvertently. Complete, corrected release follows: Vitol Upstream (Ghana) Limited and GNPC’s Sankofa -1A Well Discovers Oil and Gas Offshore Republic of GhanaGENEVA - The Sankofa -1A well drilled in its Cape Three Points Block, offshore Ghana, by the Ghana National Petroleum Corporation (GNPC) in conjunction with Vitol Upstream Ghana Limited (Vitol), encountered a net hydrocarbon column of approximately 36.3 metres comprising 33.1 metres of gas column and 3.2 metres of oil column in reservoir sands of Campanian age. The success of this well confirms the prospectivity of these Upper Cretaceous reservoir sands in the Tano/Cape Three Point Basin blocks offshore Western Ghana where the Jubilee field was discovered and is being developed. Results of RebiSmart(TM) User Trial Presented at 25th ECTRIMS Congress Show Broad Patient Acceptance of the New Electronic Delivery Device for Relapsing Multiple Sclerosis Treatment Rebif(R)GENEVA - - The Majority of Patients Found the Electronic Multidose Device “Suitable” or “Very Suitable” for Self-Injection and Rated the Device Functions as “Easy” or “Very Easy” to Use Results From Improve Study Show MRI Benefits of Rebif(R) Seen Early in Relapsing-Remitting Multiple Sclerosis Treatment and Sustained Over TimeGENEVA - - Data Presented at the 25th Congress of the European Committee for the Treatment and Research in Multiple Sclerosis (ECTRIMS) Held in Dusseldorf, Germany, From September 9-12, 2009. Vaisala Introduces a Unique Global Lightning DatasetGENEVA - The dataset will provide lightning information throughout the globe to serve the world’s meteorological institutions and other weather-dependent users. Vitol Tank Terminals International B.V. Enters a Joint Venture Agreement With MISC BerhadGENEVA - Vitol Tank Terminals International B.V. (”VTTI”), part of the Vitol Group, entered into a joint venture agreement today with MISC Berhad (”MISC”) to incorporate a joint venture company on an equal partnership basis. The joint venture company, Asia Tank Terminal Limited, will hold 100% equity interest in an oil terminal in Tanjung Bin, located in south-west Johor, Malaysia. Etinde Permit (Cameroon) Farm-in TransactionGENEVA - Vitol E and P Limited (VEP), part of the Vitol Group, is pleased to announce that it has entered into a farm-in agreement with Bowleven, the African focused oil and gas company, in respect of the Etinde Permit (Etinde, Cameroon). The Vitol Group Completes Expansion Projects at Two Key TerminalsGENEVA - The Vitol Group announced today the completion of two key projects in its storage and terminals business, VTTI (Vitol Tank Terminals International). Merck Serono Submits Application for Cladribine Tablets as Multiple Sclerosis Therapy in EuropeGENEVA, Switzerland - Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today the submission of a marketing authorization application (MAA) to the European Medicines Agency (EMEA) for Cladribine Tablets, Merck Serono’s proprietary investigational oral formulation of cladribine, as a therapy for patients with relapsing-remitting multiple sclerosis (MS). Cladribine Tablets could become the first orally administered disease-modifying therapy available for patients with MS, as all disease-modifying therapies currently approved for the treatment of MS are injectable. GONAL-f Approved in Japan for Ovulation Induction in Infertile WomenGENEVA, Switzerland - Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today announced that the Japanese Ministry of Health, Labor and Welfare has granted approval to extend the indication of GONAL-f(R) (follitropin alfa for injection) to infertile women suffering from irregular or no ovulation (oligoovulation or anovulation) due to a dysfunction in the hypothalamic- pituitary system or polycystic ovarian syndrome. GONAL-f is a recombinant follicle-stimulating hormone currently approved in Japan for the treatment of male infertility. Eukanuba Publishes its 1st Ever Photographic Study of all 340 Breeds of Dog in the WorldGENEVA - Dog lovers all over Europe now have the opportunity to own Eukanuba’s 1st ever photographic study of all breeds in a series of two unique books, which magnificently capture all 340 dog breeds recognized by the Federation Cynologique Internationale also know as the world canine organization. Get Your Puppy off to a Great Start in Life With EukanubaGENEVA - Now, Eukanuba offers you a special designed Puppy Starter Kit available at your local pet specialty store. The kit not only provide you with a 100g [trial] sachet but also offers a EUR5 money off coupon on your next purchase of Eukanuba Puppy food 2.5KG (or heavier). Can Bacteria be Good for Your Dog?GENEVA - Your dog’s intestinal tract contains 65% of his immune system and contains both good and bad bacteria, the balance which is central to his health and well being. We are all aware of bacteria that cause illness but equally there are bacteria that can actually be good for your dog. Prebiotics contained in super premium nutrition like Eukanuba, increase the good bacteria, allowing them to crowd out the bad bacteria and help maintain a healthy balance in what is a complex internal ecosystem, but how do they work? Banks Support Gunvor With USD 600m Syndicated LoanGENEVA - Leading independent oil trader Gunvor International B.V., headquartered in Amsterdam, has signed a revolving one-year credit facility of USD 600m, successfully refinancing and extending last year’s debut of USD 370m. Just as the 2008 debut was oversubscribed, this year’s refinancing also attracted significant interest and original plans for a USD 450m facility were extended by an additional USD 150m. Is There a Wolf Inside Every Dog?GENEVA, Switzerland - Ever wondered why your dog continuously scents the air and the ground, enjoys running and chasing, loves the smell and taste of meat? Well the answer lies in his natural origins - a hunter, a carnivore that caught prey and ate meat - the wolf. Maybe it’s time to take a good look at your dog again, appreciate the wolf inside and feed as his nature intended. Merck Serono Launches “Global Fertility Academy” to Provide Education and Training for the Treatment of InfertilityGENEVA, Switzerland - - Global Fertility Academy Delivers Valuable Educational Tools Aiming at Increasing Expertise and Maximizing the Success Rate of Treatment The Foundation for Research in Osteoporosis and Bone Disease (FROMO) Awards the 2009 Fellowship in Renal Physiology and PathophysiologyGENEVA - The Foundation for Research in Osteoporosis and Bone Disease (FROMO) announced the recipients of the 2009 Fellowship in Renal Physiology and Pathophysiology: Andreas Kistler, MD, PhD, Clinical Fellow at the Division of Nephrology of the University Hospital Zurich, Switzerland and Sara Damiano, PhD student in Nephrological Sciences at the Second University of Naples, Italy. The biotechnology company Amgen offered this educational grant to FROMO which is a Foundation based in Geneva to support research and teaching in the field of bone disease, in particular renal osteodystrophy which affects patients with severe renal insufficiency. Genomic Health Reports Favorable Commentary on Value of Multigene Assays From the St. Gallen Expert Consensus Meeting on the Primary Treatment of Early Breast CancerGENEVA, and REDWOOD CITY, California - - Guidelines Specify that Validated Molecular Assays Should be Considered as an Adjunct to Standard Measures in Helping Determine Chemotherapy Benefit - Merck Serono Launches RebiSmart(TM), First Electronic Injection Device for Delivery of Multiple Sclerosis Treatment Rebif(R)GENEVA - - RebiSmart(TM) is Designed to Improve Ease of Handling and Usage and Introduces the Potential for Improved Treatment Adherence for Multiple Sclerosis Patients WISeKey Will Provide Digital Certification Services to the Cecilia Attias FoundationGENEVA, Switzerland - WISeKey will be providing Digital Certification Services and use of the HighTrusted Platform to the Cecilia Attias Foundation for Women www.ceciliaattiasfoundation.org/home which provides concrete improvement in the lives of women worldwide by serving as a strategic, media, and financial platform for organizations that champion the cause of women’s equality and well-being. |
